Structure Therapeutics Inc.
GPCR
$32.12
-$2.45-7.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -93.40% | -136.85% | -79.88% | -48.88% | -42.39% |
| Total Depreciation and Amortization | 37.32% | 25.43% | 23.42% | 198.88% | 232.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,497.68% | 158.42% | 1,292.63% | 877.78% | -35.61% |
| Change in Net Operating Assets | -30.58% | 251.57% | 16.74% | -119.63% | 397.75% |
| Cash from Operations | -158.92% | -106.71% | -53.25% | -67.83% | 4.19% |
| Capital Expenditure | -129.49% | 45.67% | -93.83% | 98.62% | 16.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.91% | 124.09% | 2,073.86% | 118.51% | -708.61% |
| Cash from Investing | 73.91% | 123.93% | 2,300.07% | 118.39% | -727.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14,367.25% | -99.90% | 27.81% | -99.80% | -16.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.28% | -- | -- | 100.00% | -- |
| Cash from Financing | 7,524.44% | -99.90% | 15.24% | -99.78% | -260.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.94% | -101.80% | 45.60% | -103.31% | -2,185.58% |